In L4–6 DRG, TET1 was found in the cytoplasm and nucleus, and it was presumed to potentially enhance the progression of bone cancer pain through nuclear translocation to modulate gene expression through DNA demethylation processes. This evidence concerns the gene TET1 and bone cancer.